102
Participants
Start Date
April 18, 2013
Primary Completion Date
May 9, 2021
Study Completion Date
January 17, 2025
Dexamethasone acetate
"First step:~immunosuppressive treatment with dexamethasone"
dexamethasone and cyclophosphamide
second step (in case of insufficient response): immunosuppressive treatment with dexamethasone and cyclophosphamide
dexamethasone and rituximab
third step (in case of insufficient response): immunosuppressive treatment with dexamethasone and rituximab
St. Anna Kinderkrebsforschung e.V. CHILDREN'S CANCER RESEARCH INSTITUTE, Vienna
Kinderspital Zurich, Zurich
Hopita D'Enfants de La Timone, Marseille
CHU CAEN, Caen
G. Gaslini Institut, Genova
Chu Dijon, Dijon
University Hospital Lund, Lund
Hopital Jean Minjoz, Besançon
The Fundación para la Formación e Investigación Sanitarias de la Región de Murcia, El Palmar
Chu Toulouse Hopital Des Enfants, Toulouse
Chr Pellegrin, Bordeaux
Hopital Arnaud de Villeneuve, Montpellier
Chu Hopital Sud, Rennes
Chu Tours Hopital Clocheville, Tours
Chu de Grenoble, Grenoble
Chu Saint Etienne, Saint-Etienne
Chr de Nantes, Nantes
Chu Angers, Angers
Chu de Reims, Reims
Hopital Nancy Brabois, Vandœuvre-lès-Nancy
Centre Oscar Lambret, Lille
Chu D'Estaing, Clermont-Ferrand
CHU DE STRASBOURG HOPITAL Hautepierre, Strasbourg
Centre Leon Berard, Lyon
Institut Curie, Paris
Ch Trousseau, Paris
Chu de Rouen, Rouen
Chu Amiens, Amiens
Chu de Poitiers, Poitiers
Chu de Limoges, Limoges
Chu de Bicetre, Le Kremlin-Bicêtre
Institut de Cancerologie Gustave Roussy, Villejuif
CHU LA REUNION Site Félix Guyon, Saint-Denis
Chu de Nice Archet 2, Nice
Universitätskinderklinik, Bern
John Radcliffe Hospital, Oxford
Institut Curie
OTHER